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ABSTRACT
Objective: To evaluate the overall outcomes of patients who get definitive treatment of urethral stricture. Material & 
Method: All patients who underwent various urethral stricture management in Cipto Mangunkusumo Hospital were 
evaluated over 1 year period. Patient demographics, type of surgery, International Prostate Symptoms Score (IPSS), quality 
of life (QoL) score, flow rate (FR) and post void residual urine (PVR) of all patients were evaluated at 3 months, 6 months 
and 1 year after surgery. Results: Out of 230 urethral stricture patients, 65 patients were eligible this study. Mean patient 
age was 41.19 ± 20.44 years. 37Direct Vision Internal Urethrotomy (DVIU), 20 end-to-end anastomosis, and 8 graft 
urethroplasties were performed. All patients underwent urethral stricture management showed improvement of IPSS 
(-22.64, p < 0.001), QoL (-3.36, p < 0.001), FR (16.72 ml/s, p < 0.001) and PVR (-126.23 ml, p < 0.001). Compliant patients 
showed better improvement of IPSS and FR than non compliant patient after DVIU procedure. Overall, open surgery give 
better improvement of IPSS and FR than DVIU procedure. These differences were more pronounced in recurrent and long 
(≥2 cm) urethral stricture disease. In open surgery group, end-to-end anastomosis give better improvement in FR compared 
to graft urethroplasty. Conclusion: Patients undergoing urethral stricture management experienced a significant 
improvement in self-reported outcomes and functional uroflow studies. Overall, open surgery gives better improvement in 
FR and IPSS than DVIU procedure. In open surgery group, end-to-end anastomosis give better improvement compares to 
graft urethroplasty.
Keywords: International Prostate Symptoms Score, quality of life, flow rate, post void residual urine, urethral stricture.
ABSTRAK
Tujuan: Mengevaluasi pasien yang dilakukan perawatan definitif striktur uretra. Bahan & Cara: Semua pasien yang 
menjalani penanganan pada striktur uretra di Rumah Sakit Cipto Mangunkusumo, dievaluasi selama 1 tahun. Data 
demografi pasien, jenis operasi, International Prostate Symptoms Score (IPSS), skor quality of life (QoL), flow rate (FR) 
dan post void residual (PVR) dari semua pasien dievaluasi pada 3 bulan, 6 bulan, dan 1 tahun setelah operasi. Hasil: Dari 
230 pasien dengan striktur uretra, 65 pasien memenuhi kriteria penelitian ini. Rerata umur pasien adalah 41.19 ± 20.44 
tahun. 37 pasien menjalani Direct Vision Internal Urethrotomy (DVIU), 20 dengan end-to-end anastomosis, dan 8 dengan 
graft urethroplasties.Semua pasien yang menjalani penanganan striktur uretra menunjukkan peningkatan pada IPSS (-
22.64, p < 0.001), QoL (-3.36, p < 0.001), FR (16.72 ml/s, p < 0.001) and PVR (-126.23 ml, p < 0.001). Pasien yang disiplin 
menunjukkan hasil IPSS dan FR yang lebih baik dibandingkan dengan pasien yang tidak disiplin, setelah tindakan 
DVIU.Secara keseluruhan, operasi terbuka memberikan hasil IPSS dan FR yang lebih baik dibandingkan dengan DVIU. 
Hasil ini lebih tampak pada striktur uretra yang berulang dan panjang (≥ 2 cm).Pada kelompok operasi terbuka, end-to-end 
anastomosis memberikan perbaikan FR dibandingkan dengan graft urethroplasty. Simpulan: Pasien striktur uretra yang 
menjalani terapi definitif memberikan peningkatan yang signifikan, baik pada data subyektif maupun dengan pengukuran 
uroflowmetri. Secara keseluruhan, operasi terbuka memberikan perbaikan FR dan IPSS dibandingkan dengan DVIU. 
Pada kelompok operasi terbuka, end-to-end anastomosis memberikan perbaikan FR yang dibandingkan dengan graft 
urethroplasty.
Kata kunci: International Prostate Symptoms Score, quality of life, flow rate, post void residual, striktur uretra.
Correspondence: Ervita Mediana, c/o: Department of Urology, Faculty of Medicine/Indonesia University, Cipto Mangunkusumo 
Hospital. Jl. Diponegoro No. 71, Jakarta 10430. Office: (021) 3152892, 3923631 – 32; Fax: (021) 3145592. 
INTRODUCTION
Urethral stricture is a medical problem that 
has been known since more than 2500 years ago. 
Based on the literature of Ayurveda (660 BC), 
urethral stricture was treated using a dilator made 
1from wood or steel.  In 1817, the first internal 
prototype urethrotomy was invented. In 1848, 
2Maisonneuve invented the idea of ? ? using a 
filiform wire which was inserted into the urethra 
through a uretrotome. In 1870, Otis introduced a 
urethrotome with 2 knives, but this procedure is still 
a blind procedure.
In 1883, Heurs reported primary urethral 
anastomosis procedure for the treatment of urethral 
strictures. The technique was modified in 1922 
Heitz-Boyer. The Heitz-Boyer procedures has been 
1-6used until now.
In 1957 Ravasini reported internal 
urethrotomy (IU) with visualization and at 1971 
Sachse introduced a sharp-bladed cold-knife 
urethrotome with visualization, then at 1974 he 
reported this procedure had 80% success rate. Since 
that moment, urethrotomy technique with single cut 
at 12 o'clock has been used for urethral stricture 
1,7-13cases.
Urethral stricture disease can be congenital 
or acquired. Acquired urethral strictures can be due 
to infection, trauma, inflammation, secondary to 
radiotherapy, idiopathic or iatrogenic. The use of 
urethral catheters can cause inflammation that lead 
to gradual scar formation and eventual strictures. 
Several studies have reported the incidence of 
urethral stricture was about 33.7% in patients after 
TURP.1 In Mexico, these complications varies from 
11-29%.
Several studies have shown long-term 
results of urethral strictures treatment. Some long-
13-15term outcomes based on radiologic findings,  
13-15 13 13uroflowmetry,  continence,  post void residual,  
13urinary tract infections, post surgical instru-
13,16,17 13,15mentation,  and sexual function.  The 
paradigm for the successful treatment of urethral 
stricture disease is when there is no more 
instrumentation after definitive action.
OBJECTIVE
The purpose of this research is to evaluate 
the medium-term outcomes of patients who had 
performed definitive treatment of urethral stricture at 
Cipto Mangunkusumo hospital.
MATERIAL & METHODS
This was a prospective study of urethral 
stricture patients who had undergone definitive 
treatment from January 2001 until May 2011 at Cipto 
Mangunkusumo Hospital.
Data were collected by questionnaires that 
have been standardized internationally by IPSS 
(International Prostate Symptoms Score) and QOL 
(Quality of Life) which were sent by registered 
express mail and also an envelope and stamp inside 
the envelope for reply. Data was also collected 
through phone interview. Uroflowmetry data were 
taken from urology medical record during patient 
visit to urology clinic. Patient who had incomplete 
uroflowmetry data were called to have 
uroflowmetry, flow rate (FR) and post-void residual 
(PVR) were checked. An IPSS, QOL, FR and PVR 
were taken before definitive treatment, 3 months, 6 
months and one year after definitive action.
Data were analyzed with statistical analysis 
using SPSS v 13.0. We evaluated IPSS, QoL, FR and 
PVR score of all patients who underwent definitive 
action, then we grouped the patient by treatment to 
the patient whether DVIU (Direct Vision Internal 
Urethrotomy)/Sachse and open surgery, either end-
to-end anastomosis or graft urethroplasty, then we 
usedstatistical  paired T-test. We are looking for the 
trend of FR from all treatment, DVIU, end-to-end 
anastomosis or graft urethroplasty by using the 
Anova statistical test. And we also compared 
between DVIU and end-to-end anastomosis, DVIU 
and graft urethroplasty, and between end-to-end 
anastomosis and graft urethroplasty using post hoc 
test before operation, 3months, 6 months and 1 year 
postoperatively. We also evaluate whether there are 
significant differences between DVIU and open 
surgery, between end-to-end anastomosis and graft 
urethroplasty, between DVIU and open surgery in < 
2 cm and recurrent urethral strictures patients, and 
between end-to-end anastomosis and graft 
urethroplasty in ≥ 2.5 cm urethral stricture patients 
with statistical T-test. The results were statistically 
significant if the value of p < 0.005.
RESULTS
From 230 patients who had undergone 
definitive therapy of urethral stricture in RSCM, we 
obtained the address and phone number for 90 
patients. Of the 90 patients who were sent 
questionnaires by registered express mail, only 55 
patients who replied, another 15 patients completed 
our questionnaires after we interviewed by phone 
call. Among 70 patients who had replied our 
questionnaires, 17 patients had incomplete one year 
postoperative uroflowmetry data, so that we called 
the patients for further uroflowmetry examination. 
Only 12 patients came to complete uroflowmetry 
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test. Most of the patients who didn't come to perform 
the test were due far distance from the hospital. Sixty 
Table 1. Urethral stricture patients profile.
Category DVIU 
(n = 37) 
end-to-end anastomosis 
(n = 20) 
graft urethroplasty 
(n = 8) 
Total  
(n = 65) 
Age 
Location of urethral stricture 
Pendulous 
Bulbar 
Bulbomembranous 
Membranous 
Prostatic 
Etiology of urethral stricture 
Trauma 
Infection 
Instrumentation 
Characteristic 
New 
Recidive 
Urethral stricture length 
<2cm 
=2cm 
Treatment 
DVIU 
         Compliant 
         Non compliant 
Open surgery 
         Anastomosis 
Graft
41.35 ± 20.38 
 
0 (0%) 
20 (54.05%) 
14 (37.83%) 
3 (8.10%) 
0 (0%) 
 
23 (62.16%) 
2 (5.40%) 
12 (32.43%) 
 
27 (72.97%) 
10 (27.02%) 
 
25 (67.56%) 
12 (32.43%) 
39.78 ± 19.15 
 
2 (10%) 
7 (35%) 
9 (45%) 
1 (5%) 
1 (5%) 
 
18 (90%) 
2 (10%) 
0 (0%) 
 
16 (80%) 
4 (20%) 
 
0 (0%) 
20 (100%) 
40.22 ± 20.19 
 
3 (37.5%) 
5 (62.5%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
5 (62.5%) 
3 (37.5%) 
0 (0%) 
 
6 (75%) 
2 (25%) 
 
0 (0%) 
8 (100%) 
41.19 ± 20.44 
 
5 (7.69%) 
32 (49.23%) 
23 (35.38%) 
4 (6.15%) 
1 (1.53%) 
 
46 (70.76%) 
7 (10.76%) 
12 (18.46%) 
 
49 (75.38%) 
16 (24.61%) 
 
25 (38.46%) 
40 (61.53%) 
 
37 (56.92%) 
25 (67.56%) 
12 (32.43%) 
 
20 (30.76%) 
8 (12.30%) 
Table 2. IPSS, QoL, FR, PVR score.
 Pre-op Post-op Average 
change 
p 
All patient who underwent definitive treatment (n = 65) 
        IPSS 
 
31.05 
 
8.40 
 
-22.64 
 
< 0.001 
        QoL 4.65 1.68 -3.36 < 0.001 
        FR 3.61 20.33 16.72 < 0.001 
        PVR 146.95 20.71 -126.23 < 0.001 
Patient who had been treated with DVIU procedure (n = 37)     
        IPSS 
        QoL 
        FR 
        PVR 
28.59 
4.76 
3.59 
143.92 
10.11 
1.43 
16.45 
28.14 
-18.48 
-3.32 
12.85 
-115.77 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
Patient who had been treated by open surgery procedure (n = 28) 
        IPSS 
        QoL 
        FR 
        PVR 
 
34.29 
4.50 
3.63 
150.96 
 
6.14 
1.07 
25.46 
10.90 
 
-28.14 
-3.42 
21.82 
-140.06 
 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
Patient who had been treated by end-to-end anastomosis (n = 20) 
        IPSS 
        QoL 
        FR 
        PVR 
 
34.45 
4.45 
2.54 
145.65 
 
6 
1.05 
26.13 
10.78 
 
-28.45 
-3.40 
23.59 
-134.86 
 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
3
five patients completed the criteria, profiles of those 
patients presented in table 1.
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4Patient who had been treated by graft urethroplasty (n = 8) 
        IPSS 
       QoL 
       FR 
PVR 
 
33.88 
4.63 
6.37 
164.25 
 
6.50 
1.16 
23.78 
11.18 
 
-27.37 
-3.50 
17.41 
-153.06 
 
< 0.001 
< 0.001 
< 0.001 
< 0.001 
 Pre-op Post-op Average 
change 
p 
Table 2. IPSS, QoL, FR, PVR score (continued).
Table 3. Mean FR between DVIU, end-to-end anastomosis and graft urethroplasty.
 
Evaluation Time DVIU  
(n = 37) 
Anastomosis  
(n = 20) 
Graft  
(n = 8) 
p  p (post-hoc test) 
Pre-operative 3.59 2.54 6.37 0.001 DVIU vs graft (p 0.009) 
DVIU vs anastomosis (p 0.316) 
 
3 months post-operative 
 
 
17.35 
 
 
24.99 
 
 
23.17 
 
 
0.001 
 
graft vs anastomosis (p 0.001) 
DVIU vs graft (p 0.123) 
DVIU vs anastomosis (p 0.001) 
graft vs anastomosis (p 1.000) 
6 months post-operative 17.40 25.40 23.82 < 0.001 DVIU vs graft (p 0.066) 
DVIU vs anastomosis (p < 0.001) 
graft vs anastomosis (p 1.000) 
1 year post-operative 16.45 26.13 23.78 < 0.001 DVIU vs graft (p 0.010) 
DVIU vs anastomosis (p < 0.001) 
graft vs anastomosis (p 1.000) 
Figure 1. Trend of mean FR Pre operative, 3 months, 6 months, 1 year post operative between DVIU, end-to-end 
anastomosis and graft urethroplasty.
Based on table 2, we could evaluate the 
changes of IPSS, QOL, FR, and PVR score of all 
patients who underwent definitive therapy and also 
specific treatment whether DVIU, open surgery 
procedure, end-to-end anastomosis and graft 
urethroplasty. Based on that table we can conclude 
that all variables are statistically significant (p < 
0.001). 
Based on mean FR, we can conclude that 
between DVIU, end-to-end anastomosis and graft 
urethroplasty were statistically different for each 
evaluation period (preoperative, 3 months, 6 months 
and 1 year postoperative). Based on statistical post-
hoc test, mean FR of DVIU vs end-to-end 
anastomosis were statisticaly significant on 3 
months and 6 months post operative evaluation.
Figure 1 shows the pattern of FR trend 
between DVIU, graft and anastomosis. We could see 
that FR score of anastomosis are always higher than 
graft and DVIU. 
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Table 4. IPSS, QoL, FR and PVR changes in DVIU 
patients between compliant (n = 25) and 
non compliant (n = 12) groups.
  
Average
 changes  p 
IPSS Compliant -29.14 0.001 
 Non Compliant -18.47  
QoL Compliant -3.41 0.552 
 Non Compliant -3.32  
FR Compliant 21.93 0.010 
 Non Compliant 12.95  
PVR Compliant -145.77 0.217 
 Non Compliant -115.22  
 
Compliant: Patient who had routine bougination procedure after 
operation.
Non compliant: Patient who didn't have bougination procedure 
after operation.
Compliant patients had better IPSS (p < 
0.001) and FR (p < 0.010) improvement than non 
compliant patients in post DVIU procedure.
Table 5. Average changes of IPSS, QoL, FR and 
PVR between DVIU (n = 37) and open 
surgery (n = 28).
 
IPSS DVIU -18.48 < 0.001 
 Open  -28.14  
QoL DVIU -3.32 0.511 
 Open -3.42  
FR DVIU 12.85 < 0.001 
 Open 21.82  
PVR DVIU -115.77 0.217 
Open -140.06  
   
Average
changes p 
Table 5 shows average changes of IPSS, 
QoL, FR and PVR in DVIU and open surgery, the 
statistical significant changes are significant in IPSS 
and FR.
Table 6 shows average changes of IPSS, 
QoL, FR and PVR between end-to-end anastomosis 
and graft urethroplasty, and a statistically significant 
difference was the average changes of FR, where 
end-to-end anastomosis provide greater changes 
than graft urethroplasty with a p value of 0.008.
Open surgery gives better results than 
DVIU, especially when viewed from the value of 
IPSS (p < 0.001) and FR (p < 0.011).
IPSS Anastomosis -28.45 0.314 
 Graft -27.37  
QoL Anastomosis -3.4 0.685 
 Graft -3.5  
FR Anastomosis 23.59 0.008 
 Graft 17.41  
PVR Anastomosis -134.86 0.589 
Graft -153.06
   
Average
changes p 
Table 6. Average changes of IPSS, QoL, FR and 
PVR between end-to-end anastomosis (n = 
20) and graft urethroplasty (n = 8).
Table 7. Average changes of IPSS, QoL, FR and 
PVR in recurrent urethral stricture 
patients between DVIU (n = 10) and open
 surgery (n = 6)
IPSS DVIU -19.14 0.001 
 Open -28.55  
QoL DVIU -3.28 0.628 
 Open -3.44  
FR DVIU 13.57 0.011 
 Open 21.33  
PVR DVIU -85.66 0.301 
Open -127.42  
   
Average
changes p 
Table 8. Average changes of IPSS, QoL, FR and 
PVR in ≥ 2 cm urethral stricture patients 
between DVIU (n = 12) and open surgery 
(n = 28).
IPSS DVIU -20.27 <0.001 
 Open -28.00  
QoL DVIU -3.27 0.238 
 Open -3.52  
FR DVIU 12.88 0.001 
 Open 21.77  
PVR DVIU -117.27 0.332 
Open -148.94  
   
Average
changes p 
In patients with ≥ 2 cm urethral stricture 
disease, better increase of IPSS (p < 0.000) and FR (p 
< 0.001) are seen when performed open surgery 
compared to DVIU.
6Table 9. Average changes of IPSS, QoL, FR and 
PVR in ≥ 2.5 cm urethral stricture patients 
between end-to-end anastomosis (n = 11) 
and graft urethroplasty (n = 8).
IPSS Anastomosis -28.14 0.321 
 Graft -27.97  
QoL Anastomosis -3.4 0.684 
 Graft -3.5  
FR Anastomosis 22.43 0.051 
 Graft 18.32  
PVR Anastomosis -133.87 0.577 
Graft -152 09
   
Average
changes p 
There were no statistically significant 
difference between end-to-end anastomosis and 
graft urethroplasty inurethral stricture patients ≥ 2.5 
cm length.
DISCUSSION
The subjects of this study were 65 patients, 
with average age was 41.19 ± 20.44 years. A total of 
37 patients underwent DVIU procedure, 20 patients 
end-to-end anastomosis and 8 patients were graft 
urethroplasty. In DVIU group, 20 patients were 
bulbar stricture, 14 patients were bulbomembranous 
stricture, and 3 patients were membranous strictures. 
In end-to-end anastomosis group, 2 patients were 
pendular strictures, 7 patients were bulbar stricture, 9 
patients were bulbomembranous stricture, 1 patient 
were membranous stricture and 1 patients was 
prostatic stricture. In graft urethroplasty group, 3 
patients were pendular stricture and 5 patients were 
bulbar stricture. In 40 patients, length of the stricture 
were ≥ 2 cm, and 12 patients still underwent DVIU 
procedure. In 16 recurrent stricture patients, 10 
patients still underwent DVIU procedure. In 19 
patients, length of the stricture were ≥ 2.5 cm, with 11 
patients performed end-to-end anastomosis and 8 
patients were graft urethroplasty.
Treatment of urethral strictures requires 
good planning to obtain satisfactory results. 
Minimally invasive procedures such as DVIU, 
urethral dilation, and urethral stenting can be 
performed in some patients, but with a high failure 
18,19rate.  DVIU is dilatation procedure for initial 
treatment of short urethral stricture (< 1 cm) in pars 
18,19bulbosa.  The paradigm for the successful 
treatment of urethral stricture is when there is no 
more instrumentation after definitive treatment. 
Therefore, open surgery should be the first option on 
the longer stricture or on the strictures that have 
failed in minimally invasive therapies. In our study 
found that in patients with long urethral stricture (≥ 2 
cm) and recurrent strictures, changes in IPSS and FR 
value generated will be significantly better when 
performed open surgery.
The location and length of urethral stricture 
is a very important factor in determining the choice 
of definitive therapy. Strictures on navicularis fossa 
better treated by penile skin fasciocutaneous flaps, 
because the end-to-end anastomosis can produce a 
high failure rate, shortening of the penis, or the 
20formation of chordee.  Management of the long 
pendular stricture is still a controversy. Some 
21opinions favor dorsal onlay buccal mucosal graft,  
but some are saying penile skin fasciocutaneous flap 
22 is better. In short urethral strictures (< 2.5 cm) in the 
pars bulbosa, end-to-end anastomosis could be the 
23,24right choice.  Pars bulbosa stricture with the length 
between 2.5 to 5 cm can be done by buccal mucosal 
onlay graft. On longer pars bulbosa stricture or failed 
post urethroplasty with buccal mucosal graft, penile 
fascsiocutaneus onlay flap could be used. Our study 
shows the results of operations of the ≥ 2.5 cm 
stricture between end-to-end anastomosis and 
buccal mucosal graft. There was no significant 
difference from the value of IPSS, QOL, FR and 
PVR between both technique.
At our institution, all patients underwent 
buccal mucosal graft, because the buccal mucosal 
graft is better than others, such as penile skin graft, 
scrotal skin, extragenital skin, bladder mucosa and 
colonic mucosa. The advantage of the buccal mucosa 
is the ease of planting, viability, resistance to 
infection and the characteristics of epithelial tissue 
with a thick, high content of elastic tissue and thin 
25lamina propia.
Based on the meta-analysis by Yuri P, et al. 
in patients with short bulbar urethra stricture (≤ 3 
cm), there is a statistically significant difference 
between end-to-end anastomosis and buccal 
mucosal graft when viewed from the recurrence rate 
with p value 0.016 and RR 0.38. This is because end-
to-end anastomosis excised all fibrotic tissue, 
whereas the buccal mucosal graft surgery success 
rate is influenced by the formation of scar tissue in 
the graft (fibrosis), blood flow to the graft and graft 
25quality. Graft quality may decline in smokers.  In 
our study, it could be seen from the differences in the 
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7average increase in the value of FR in which end-to-
end anastomosis is better than graft with p value 
0.008.
In general, the characteristics of the study 
subjects among patients who performed DVIU, end-
to-end anastomosis and graft urethroplasty were 
similar. Different characteristics is the length of 
stricture that is one of the limitations of this study. 
Another limitation is the limited number of subjects, 
especially in patients who underwent graft 
urethroplasty by only 8 patients, if compared to 
DVIU with total 37 patients and end-to-end 
anastomosis 20 patients. Therefore, further study 
with more uniform characteristics of the subjects and 
increase the number of the subjects are needed.
CONCLUSION
Patients undergoing urethral stricture 
management experienced a significant improvement 
in self-reported outcomes and functional uroflow 
studies. Overall, open surgery gives better 
improvement in FR and IPSS than DVIU procedure. 
In open surgery group, end-to-end anastomosis give 
better improvement compared to graft urethroplasty.
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